APS 0 3 0 3 O
and 4 7 4 7 O
positive 8 16 8 16 O
for 17 20 17 20 O
LAC 21 24 21 24 O
on 25 27 25 27 O
two 28 31 28 31 O
or 32 34 32 34 O
more 35 39 35 39 O
occasions 40 49 40 49 O
greater 50 57 50 57 O
than 58 62 58 62 O
12 63 65 63 65 B-lower_bound
weeks 66 71 66 71 I-lower_bound
apart 72 77 72 77 O
within 78 84 78 84 O
the 85 88 85 88 O
previous 89 97 89 97 B-upper_bound
18 98 100 98 100 I-upper_bound
months 101 107 101 107 I-upper_bound
and 108 111 108 111 O
confirmed 112 121 112 121 O
by 122 124 122 124 O
review 125 131 125 131 O
of 132 134 132 134 O
medical 135 142 135 142 O
records 143 150 143 150 O
and 151 154 151 154 O
core 155 159 155 159 O
laboratory 160 170 160 170 O
testing 171 178 171 178 O

Active 0 6 179 185 B-chronic_disease
infection 7 16 186 195 I-chronic_disease
, 16 17 195 196 O
e.g. 18 22 197 201 O
, 22 23 201 202 O
chronic 24 31 203 210 B-chronic_disease
hepatitis 32 41 211 220 I-chronic_disease
B 42 43 221 222 I-chronic_disease

History 0 7 223 230 O
of 8 10 231 233 O
peripheral 11 21 234 244 B-chronic_disease
demyelinating 22 35 245 258 I-chronic_disease
disease 36 43 259 266 I-chronic_disease
or 44 46 267 269 O
Guillian 47 55 270 278 B-chronic_disease
- 55 56 278 279 I-chronic_disease
Barre 56 61 279 284 I-chronic_disease
syndrome 62 70 285 293 I-chronic_disease

History 0 7 294 301 O
of 8 10 302 304 O
recurrent 11 20 305 314 B-chronic_disease
infection 21 30 315 324 I-chronic_disease
, 30 31 324 325 O
e.g. 32 36 326 330 O
, 36 37 330 331 O
recurrent 38 47 332 341 B-chronic_disease
cellulitis 48 58 342 352 I-chronic_disease
, 58 59 352 353 O
or 60 62 354 356 O
opportunistic 63 76 357 370 B-chronic_disease
infection 77 86 371 380 I-chronic_disease

History 0 7 381 388 O
of 8 10 389 391 O
tuberculosis 11 23 392 404 B-chronic_disease
or 24 26 405 407 O
untreated 27 36 408 417 O
positive 37 45 418 426 O
PPD 46 49 427 430 O

Hypertension 0 12 431 443 B-chronic_disease
( 13 14 444 445 O
BP 14 16 445 447 B-clinical_variable
> 17 18 448 449 O
140/90 18 24 449 455 B-lower_bound
) 24 25 455 456 O
present 26 33 457 464 O
at 34 36 465 467 O
screening 37 46 468 477 O

Known 0 5 478 483 O
contraindications 6 23 484 501 O
or 24 26 502 504 O
relative 27 35 505 513 O
contraindications 36 53 514 531 O
to 54 56 532 534 O
certolizumab 57 69 535 547 B-allergy_name

Laboratory 0 10 548 558 B-clinical_variable
hematocrit 11 21 559 569 I-clinical_variable
> 22 23 570 571 O
26 23 25 571 573 B-lower_bound
% 25 26 573 574 I-lower_bound
at 27 29 575 577 O
time 30 34 578 582 O
of 35 37 583 585 O
screening 38 47 586 595 O

Platelet 0 8 596 604 B-clinical_variable
count 9 14 605 610 I-clinical_variable
< 15 16 611 612 O
100,000 16 23 612 619 B-upper_bound
per 24 27 620 623 I-upper_bound
microliter 28 38 624 634 I-upper_bound

Prior 0 5 635 640 O
adverse 6 13 641 648 O
reaction 14 22 649 657 O
to 23 25 658 660 O
certolizumab 26 38 661 673 B-allergy_name
or 39 41 674 676 O
o 42 43 677 678 O
ther 44 48 679 683 O
anti 49 53 684 688 B-allergy_name
- 53 54 688 689 I-allergy_name
TNF 54 57 689 692 I-allergy_name
- 57 58 692 693 I-allergy_name
Î± 58 59 693 694 I-allergy_name
agent 60 65 695 700 I-allergy_name

SLE 0 3 701 704 B-chronic_disease
patients 4 12 705 713 O
requiring 13 22 714 723 O
prednisone 23 33 724 734 B-clinical_variable
> 34 35 735 736 O
10 35 37 736 738 B-lower_bound
mg 38 40 739 741 I-lower_bound
/ 40 41 741 742 I-lower_bound
day 41 44 742 745 I-lower_bound

Serum 0 5 746 751 B-clinical_variable
creatinine 6 16 752 762 I-clinical_variable
> 17 18 763 764 O
1.2 18 21 764 767 B-lower_bound
mg 22 24 768 770 I-lower_bound
/ 24 25 770 771 I-lower_bound
dL 25 27 771 773 I-lower_bound

Type 0 4 774 778 B-chronic_disease
1 5 6 779 780 I-chronic_disease
or 7 9 781 783 I-chronic_disease
Type 10 14 784 788 I-chronic_disease
2 15 16 789 790 I-chronic_disease
diabetes 17 25 791 799 I-chronic_disease
antedating 26 36 800 810 O
pregnancy 37 46 811 820 B-pregnancy

Women 0 5 821 826 B-gender
currently 6 15 827 836 O
taking 16 22 837 843 O
prednisone 23 33 844 854 B-treatment
greater 34 41 855 862 O
than 42 46 863 867 O
10 47 49 868 870 B-lower_bound
mg 50 52 871 873 I-lower_bound
daily 53 58 874 879 O

Women 0 5 880 885 B-gender
with 6 10 886 890 O
HIV 11 14 891 894 B-chronic_disease
, 14 15 894 895 O
Hepatitis 16 25 896 905 B-chronic_disease
B 26 27 906 907 I-chronic_disease
or 28 30 908 910 O
Hepatitis 31 40 911 920 B-chronic_disease
C 41 42 921 922 I-chronic_disease
positive 43 51 923 931 O
status 52 58 932 938 O

Women 0 5 939 944 B-gender
with 6 10 945 949 O
a 11 12 950 951 O
tuberculin 13 23 952 962 B-treatment
skin 24 28 963 967 I-treatment
test 29 33 968 972 O
induration 34 44 973 983 O
of 45 47 984 986 O
5 48 49 987 988 B-lower_bound
mm 50 52 989 991 I-lower_bound
or 53 55 992 994 O
greater 56 63 995 1002 O
; 63 64 1002 1003 O
or 65 67 1004 1006 O
positive 68 76 1007 1015 O
quantiFERON 77 88 1016 1027 B-treatment
- 88 89 1027 1028 I-treatment
gold 89 93 1028 1032 I-treatment
test 94 98 1033 1037 O

Women 0 5 1038 1043 B-gender
with 6 10 1044 1048 O
urinary 11 18 1049 1056 B-clinical_variable
excretion 19 28 1057 1066 I-clinical_variable
with 29 33 1067 1071 O
greater 34 41 1072 1079 O
than 42 46 1080 1084 O
500 47 50 1085 1088 B-lower_bound
mg 51 53 1089 1091 I-lower_bound
( 54 55 1092 1093 I-lower_bound
0.5 55 58 1093 1096 I-lower_bound
g 59 60 1097 1098 I-lower_bound
) 60 61 1098 1099 I-lower_bound
per 62 65 1100 1103 I-lower_bound
day 66 69 1104 1107 I-lower_bound
( 70 71 1108 1109 O
spot 71 75 1109 1113 B-clinical_variable
urine 76 81 1114 1119 I-clinical_variable
protein 82 89 1120 1127 I-clinical_variable
/ 89 90 1127 1128 I-clinical_variable
creatinine 90 100 1128 1138 I-clinical_variable
ration 101 107 1139 1145 I-clinical_variable
0.5 108 111 1146 1149 O
) 111 112 1149 1150 O

